Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

309. Brawer MK, Peehl DM, Stamey TA,
Bostwick DG (1985). Keratin immunoreactivity
in the benign and neoplastic human
prostate. Cancer Res 45: 3663-3667.
310. Brawley OW (1997). Prostate carcinoma
incidence and patient mortality: the
effects of screening and early detection.
Cancer 80: 1857-1863.
311. Brawn PN (1987). The characteristics
of embryonal carcinoma cells in teratocarcinomas.
Cancer 59: 2042-2046.
312. Brennan MK, Srigley JR (1999).
Brenner tumours of testis and the paratestis:
case report and a literature review.
J Urol Pathol 10: 219-228.
313. Brennan P, Bogillot O, Cordier S,
Greiser E, Schill W, Vineis P, Lopez-
Abente G, Tzonou A, Chang-Claude J,
Bolm-Audorff U, Jockel KH, Donato F,
Serra C, Wahrendorf J, Hours M,
T’Mannetje A, Kogevinas M, Boffetta P
(2000). Cigarette smoking and bladder
cancer in men: a pooled analysis of 11
case-control studies. Int J Cancer 86: 289-
294.
314. Brennick JB, O’Connell JX, Dickersin
GR, Pilch BZ, Young RH (1994). Lipofuscin
pigmentation (so-called “melanosis”) of
the prostate. Am J Surg Pathol 18: 446-454.
315. Breslow N, Beckwith JB, Ciol M,
Sharples K (1988). Age distribution of
Wilms’ tumor: report from the National
Wilms’ Tumor Study. Cancer Res 48: 1653-
1657.
316. Breslow N, Chan CW, Dhom G, Drury
RA, Franks LM, Gellei B, Lee YS, Lundberg
S, Sparke B, Sternby NH, Tulinius H (1977).
Latent carcinoma of prostate at autopsy in
seven areas. The International Agency for
Research on Cancer, Lyons, France. Int J
Cancer 20: 680-688.
317. Breslow N, Olshan A, Beckwith JB,
Green DM (1993). Epidemiology of Wilms
tumor. Med Pediatr Oncol 21: 172-181.
318. Breslow NE, Churchill G, Nesmith B,
Thomas PR, Beckwith JB, Othersen HB,
D’Angio GJ (1986). Clinicopathologic features
and prognosis for Wilms’ tumor
patients with metastases at diagnosis.
Cancer 58: 2501-2511.
319. Bretheau D, Lechevallier E, Jean F,
Rampal M, Coulange C (1993). [Tumors of
the superior urinary tract and associated
bladder tumors: clinical and etiological
aspects]. Prog Urol 3: 979-987.
320. Brieger J, Weidt EJ, Schirmacher P,
Storkel S, Huber C, Decker HJ (1999).
Inverse regulation of vascular endothelial
growth factor and VHL tumor suppressor
gene in sporadic renal cell carcinomas is
correlated with vascular growth: an in
vivo study on 29 tumors. J Mol Med 77:
505-510.
321. Bringuier PP, McCredie M, Sauter G,
Bilous M, Stewart J, Mihatsch MJ,
Kleihues P, Ohgaki H (1998). Carcinomas
of the renal pelvis associated with smoking
and phenacetin abuse: p53 mutations
and polymorphism of carcinogenmetabolising
enzymes. Int J Cancer 79:
531-536.
322. Bringuier PP, Tamimi Y, Schuuring E,
Schalken J (1996). Expression of cyclin D1
and EMS1 in bladder tumours; relationship
with chromosome 11q13 amplification.
Oncogene 12: 1747-1753.
323. Brinker DA, Potter SR, Epstein JI
(1999). Ductal adenocarcinoma of the
prostate diagnosed on needle biopsy: correlation
with clinical and radical prostatectomy
findings and progression. Am J
Surg Pathol 23: 1471-1479.
324. Broggi G, Appetito C, di Leone L,
Ciprandi G, Menichella P, Broggi M,
Boldrini R, Zaccara A (1991). Dermoid cyst
in undescended testis in a 9-year-old boy.
Urol Int 47: 110-112.
325. Brooks JD, Weinstein M, Lin X, Sun Y,
Pin SS, Bova GS, Epstein JI, Isaacs WB,
Nelson WG (1998). CG island methylation
changes near the GSTP1 gene in prostatic
intraepithelial neoplasia. Cancer
Epidemiol Biomarkers Prev 7: 531-536.
326. Brosman SA (1979). Testicular tumors
in prepubertal children. Urology 13: 581-
588.
327. Brouland JP, Meeus F, Rossert J,
Hernigou A, Gentric D, Jacquot C, Diebold
J, Nochy D (1994). Primary bilateral B-cell
renal lymphoma: a case report and review
of the literature. Am J Kidney Dis 24: 586-
589.
328. Brown DF, Chason DP, Schwartz LF,
Coimbra CP, Rushing EJ (1998).
Supratentorial giant cell ependymoma: a
case report. Mod Pathol 11: 398-403.
329. Brown JM (1975). Cystic partially differentiated
nephroblastoma. J Pathol 115:
175-178.
330. Brown NJ (1976). Teratomas and
yolk-sac tumours. J Clin Pathol 29: 1021-
1025.
331. Bruneton JN, Drouillard J, Normand
F, Tavernier J, Thyss A, Schneider M
(1987). Non-renal urological lymphomas.
ROFO Fortschr Geb Rontgenstr
Nuklearmed 146: 42-46.
332. Bryan GT (1969). Role of tryptophan
metabolites in urinary bladder cancer. Am
Ind Hyg Assoc J 30: 27-34.
333. Bryant J (1995). Granular cell tumor of
penis and scrotum. Urology 45: 332-334.
334. Bubendorf L, Grilli B, Sauter G,
Mihatsch MJ, Gasser TC, Dalquen P
(2001). Multiprobe FISH for enhanced
detection of bladder cancer in voided
urine specimens and bladder washings.
Am J Clin Pathol 116: 79-86.
335. Bubendorf L, Sauter G, Moch H,
Schmid HP, Gasser TC, Jordan P,
Mihatsch MJ (1996). Ki67 labelling index:
an independent predictor of progression
in prostate cancer treated by radical
prostatectomy. J Pathol 178: 437-441.
336. Budia Alba A, Queipo Zaragoza JA,
Perez Ebri ML, Fuster Escriva A, Vera
Donoso DC, Vera Sempere FJ, Jimenez
Cruz JF (1999). [Comparative study of pure
epidermoid carcinoma of the bladder and
transitional cell carcinoma with squamous
or mixed differentiated foci]. Actas
Urol Esp 23: 111-118.
337. Bue P, Wester K, Sjostrom A,
Holmberg A, Nilsson S, Carlsson J,
Westlin JE, Busch C, Malmstrom PU
(1998). Expression of epidermal growth
factor receptor in urinary bladder cancer
metastases. Int J Cancer 76: 189-193.
338. Bugert P, Kovacs G (1996). Molecular
differential diagnosis of renal cell carcinomas
by microsatellite analysis. Am J
Pathol 149: 2081-2088.
339. Bugert P, von Knobloch R, Kovacs G
(1998). Duplication of two distinct regions
on chromosome 5q in non-papillary renalcell
carcinomas. Int J Cancer 76: 337-340.
340. Bullock MJ, Srigley JR, Klotz LH,
Goldenberg SL (2002). Pathologic effects
of neoadjuvant cyproterone acetate on
nonneoplastic prostate, prostatic intraepithelial
neoplasia, and adenocarcinoma: a
detailed analysis of radical prostatectomy
specimens from a randomized trial. Am J
Surg Pathol 26: 1400-1413.
341. Bullock PS, Thoni DE, Murphy WM
(1987). The significance of colonic mucosa
(intestinal metaplasia) involving the urinary
tract. Cancer 59: 2086-2090.
342. Bunesch Villalba L, Bargallo Castello
X, Vilana Puig R, Burrel Samaranch M, Bru
Saumell C (2001). Lymphoma of the penis:
sonographic findings. J Ultrasound Med
20: 929-931.
343. Burgess NA, Lewis DC, Matthews PN
(1992). Primary carcinoid of the bladder. Br
J Urol 69: 213-214.
344. Burgues O, Ferrer J, Navarro S,
Ramos D, Botella E, Llombart-Bosch A
(1999). Hepatoid adenocarcinoma of the
urinary bladder. An unusual neoplasm.
Virchows Arch 435: 71-75.
345. Burke AP, Mostofi FK (1988).
Intratubular malignant germ cells in testicular
biopsies: clinical course and identification
by staining for placental alkaline
phosphatase. Mod Pathol 1: 475-479.
346. Burke AP, Mostofi FK (1988). Placental
alkaline phosphatase immunohistochemistry
of intratubular malignant germ cells
and associated testicular germ cell
tumors. Hum Pathol 19: 663-670.
347. Burke AP, Mostofi FK (1993).
Spermatocytic seminoma: A clinicopathologic
study of 79 cases. J Urol Pathol 1: 21-
32.
348. Burrig KF, Pfitzer P, Hort W (1990).
Well-differentiated papillary mesothelioma
of the peritoneum: a borderline
mesothelioma. Report of two cases and
review of literature. Virchows Arch A
Pathol Anat Histopathol 417: 443-447.
349. Burt AD, Cooper G, MacKay C, Boyd
JF (1987). Dermoid cyst of the testis. Scott
Med J 32: 146-148.
350. Burt ME, Javadpour N (1981). Germcell
tumors in patients with apparently
normal testes. Cancer 47: 1911-1915.
351. Bussey KJ, Lawce HJ, Olson SB,
Arthur DC, Kalousek DK, Krailo M, Giller R,
Heifetz S, Womer R, Magenis RE (1999).
Chromosome abnormalities of eighty-one
pediatric germ cell tumors: sex-, age-,
site-, and histopathology-related differences—A
Children’s Cancer Group study.
Genes Chromosomes Cancer 25: 134-146.
352. Buszello H, Muller-Mattheis V,
Ackermann R (1994). [Value of computerized
tomography in detection of lymph
node metastases in bladder cancer].
Urologe A 33: 243-246.
353. Butnor KJ, Sporn TA, Hammar SP,
Roggli VL (2001). Well-differentiated papillary
mesothelioma. Am J Surg Pathol 25:
1304-1309.
354. Byar DP, Mostofi FK (1972).
Carcinoma of the prostate: prognostic
evaluation of certain pathologic features
in 208 radical prostatectomies. The
Veterans Administrative Cooperative
Urologic Research Groups. Cancer 30: 5-
13.
355. Byard RW, Bell ME, Alkan MK (1987).
Primary carcinosarcoma: a rare cause of
unilateral ureteral obstruction. J Urol 137:
732-733.
356. Cabanas RM (1977). An approach for
the treatment of penile carcinoma. Cancer
39: 456-466.
357. Caccamo D, Socias M, Truchet C
(1991). Malignant Brenner tumor of the
testis and epididymis. Arch Pathol Lab
Med 115: 524-527.
358. Caduff RF, Schwobel MG, Willi UV,
Briner J (1997). Lymphangioma of the right
kidney in an infant boy. Pediatr Pathol Lab
Med 17: 631-637.
359. Cairns P, Evron E, Okami K, Halachmi N,
Esteller M, Herman JG, Bose S, Wang SI,
Parsons R, Sidransky D (1998). Point mutation
and homozygous deletion of
PTEN/MMAC1 in primary bladder cancers.
Oncogene 16: 3215-3218.
360. Cairns P, Proctor AJ, Knowles MA
(1991). Loss of heterozygosity at the RB
locus is frequent and correlates with muscle
invasion in bladder carcinoma.
Oncogene 6: 2305-2309.
361. Cairns P, Shaw ME, Knowles MA (1993).
Initiation of bladder cancer may involve
deletion of a tumour-suppressor gene on
chromosome 9. Oncogene 8: 1083-1085.
362. Call KM, Glaser T, Ito CY, Buckler AJ,
Pelletier J, Haber DA, Rose EA, Kral A,
Yeger H, Lewis WH, Jones C, Housman DE
(1990). Isolation and characterization of a
zinc finger polypeptide gene at the human
chromosome 11 Wilms’ tumor locus. Cell 60:
509-520.
363. Cameron KM, Lupton CH (1976).
Inverted papilloma of the lower urinary
tract. Br J Urol 48: 567-577.
364. Campani R, Bottinelli O, Calliada F,
Coscia D (1998). The latest in ultrasound:
three-dimensional imaging. Part II. Eur J
Radiol 27 Suppl 2: S183-S187.
365. Campo E, Algaba F, Palacin A, Germa R,
Sole-Balcells FJ, Cardesa A (1989).
Placental proteins in high-grade urothelial
neoplasms. An immunohistochemical study
of human chorionic gonadotropin, human
placental lactogen, and pregnancy-specific
beta-1-glycoprotein. Cancer 63: 2497-2504.
366. Cano-Valdez AM, Chanona-Vilchis J,
Dominguez-Malagon H (1999). Large cell
calcifying Sertoli cell tumor of the testis: a
clinicopathological, immunohistochemical,
and ultrastructural study of two cases.
Ultrastruct Pathol 23: 259-265.
367. Cantor KP, Lynch CF, Hildesheim ME,
Dosemeci M, Lubin J, Alavanja M, Craun G
(1998). Drinking water source and chlorination
byproducts. I. Risk of bladder cancer.
Epidemiology 9: 21-28.
368. Capella C, Eusebi V, Rosai J (1984).
Primary oat cell carcinoma of the kidney.
Am J Surg Pathol 8: 855-861.
369. Cappellen D, de Oliveira C, Ricol D, de
Medina S, Bourdin J, Sastre-Garau X,
Chopin D, Thiery JP, Radvanyi F (1999).
Frequent activating mutations of FGFR3 in
human bladder and cervix carcinomas. Nat
Genet 23: 18-20.
370. Carbonara C, Longa L, Grosso E,
Mazzucco G, Borrone C, Garre ML,
Brisigotti M, Filippi G, Scabar A, Giannotti A,
Falzoni P, Monga G, Garini G, Gabrielli M,
Riegler P, Danesino C, Ruggieri M, Magro G,
Migone N (1996). Apparent preferential loss
of heterozygosity at TSC2 over TSC1 chromosomal
region in tuberous sclerosis
hamartomas. Genes Chromosomes Cancer
15: 18-25.
371. Carcao MD, Taylor GP, Greenberg ML,
Bernstein ML, Champagne M, Hershon L,
Baruchel S (1998). Renal-cell carcinoma in
children: a different disorder from its adult
counterpart? Med Pediatr Oncol 31: 153-
158.
372. Cardenosa G, Papanicolaou N, Fung CY,
Tung GA, Yoder IC, Althausen AF, Shipley
WU (1990). Spermatic cord sarcomas: sonographic
and CT features. Urol Radiol 12: 163-
167.
373. Cardillo MR, Castagna G, Memeo L, de
Bernardinis E, di Silverio F (2000). Epidermal
growth factor receptor, MUC-1 and MUC-2
in bladder cancer. J Exp Clin Cancer Res 19:
225-233.
References 311